Shunxing Rong

1.1k total citations · 1 hit paper
15 papers, 659 citations indexed

About

Shunxing Rong is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Shunxing Rong has authored 15 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Shunxing Rong's work include Cholesterol and Lipid Metabolism (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Shunxing Rong is often cited by papers focused on Cholesterol and Lipid Metabolism (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Shunxing Rong collaborates with scholars based in United States, China and Chile. Shunxing Rong's co-authors include John S. Parks, Qiang Cao, Nilamadhab Mishra, Joyce J. Repa, Jay D. Horton, Jeffrey G. McDonald, Vı́ctor Cortés, Mingfeng Xia, Robert E. Hammer and Shirya Rashid and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Shunxing Rong

14 papers receiving 652 citations

Hit Papers

DGAT2 inhibition blocks SREBP-1 cleavage and improves hep... 2024 2026 2025 2024 10 20 30 40
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER
    2024 46 citations Shunxing Rong, Mingfeng Xia et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shunxing Rong United States 12 295 207 190 110 104 15 659
Gabriela Suchánková United States 8 283 1.0× 212 1.0× 145 0.8× 138 1.3× 46 0.4× 13 645
Karen M. Kassel United States 15 268 0.9× 113 0.5× 369 1.9× 53 0.5× 81 0.8× 20 800
Tetsuya Kitamine Japan 12 441 1.5× 355 1.7× 117 0.6× 140 1.3× 110 1.1× 14 789
Kavita Jadhav United States 15 325 1.1× 165 0.8× 294 1.5× 82 0.7× 48 0.5× 18 699
Ariane Pessentheiner United States 13 296 1.0× 120 0.6× 248 1.3× 101 0.9× 99 1.0× 20 765
Hélène Dehondt France 15 518 1.8× 326 1.6× 280 1.5× 207 1.9× 78 0.8× 18 1.1k
Miguel Arévalo Rodríguez Canada 8 237 0.8× 217 1.0× 122 0.6× 142 1.3× 60 0.6× 13 594
Jeltje R. Goudriaan Netherlands 7 242 0.8× 113 0.5× 149 0.8× 101 0.9× 40 0.4× 9 518
Jingmei Song China 11 202 0.7× 216 1.0× 93 0.5× 49 0.4× 93 0.9× 22 540
Kaushala S. Jayawardana Australia 10 384 1.3× 67 0.3× 179 0.9× 100 0.9× 46 0.4× 12 654

Countries citing papers authored by Shunxing Rong

Since Specialization
Citations

This map shows the geographic impact of Shunxing Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunxing Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunxing Rong more than expected).

Fields of papers citing papers by Shunxing Rong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunxing Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunxing Rong. The network helps show where Shunxing Rong may publish in the future.

Co-authorship network of co-authors of Shunxing Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Shunxing Rong. A scholar is included among the top collaborators of Shunxing Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunxing Rong. Shunxing Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chen, Hongwen, Gonçalo Vale, Nadia Elghobashi‐Meinhardt, et al.. (2025). Molecular insights into human phosphatidylserine synthase 2 and its regulation of SREBP pathways. Proceedings of the National Academy of Sciences. 122(20). e2501177122–e2501177122.
2.
Rong, Shunxing, Mingfeng Xia, Gonçalo Vale, et al.. (2024). DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER. Cell Metabolism. 36(3). 617–629.e7. 46 indexed citations breakdown →
3.
Zhang, Zhao, Shunxing Rong, Jeffrey A. SoRelle, et al.. (2022). Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesity. Nature Communications. 13(1). 4136–4136. 12 indexed citations
4.
Xia, Mingfeng, Preethi Chandrasekaran, Shunxing Rong, Xiaorong Fu, & Matthew A. Mitsche. (2020). Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver. Journal of Lipid Research. 62. 100031–100031. 43 indexed citations
5.
Xia, Mingfeng, Shunxing Rong, Xiaopeng Zhu, et al.. (2020). Osteocalcin and Non-Alcoholic Fatty Liver Disease: Lessons From Two Population-Based Cohorts and Animal Models. Journal of Bone and Mineral Research. 36(4). 712–728. 29 indexed citations
6.
Rong, Shunxing, Vı́ctor Cortés, Shirya Rashid, et al.. (2017). Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice. eLife. 6. 107 indexed citations
7.
Rong, Shunxing, Jeffrey G. McDonald, & Luke J. Engelking. (2017). Cholesterol auxotrophy and intolerance to ezetimibe in mice with SREBP-2 deficiency in the intestine. Journal of Lipid Research. 58(10). 1988–1998. 11 indexed citations
8.
Cao, Qiang, et al.. (2014). Histone Deacetylase 9 Represses Cholesterol Efflux and Alternatively Activated Macrophages in Atherosclerosis Development. Arteriosclerosis Thrombosis and Vascular Biology. 34(9). 1871–1879. 161 indexed citations
9.
Cortés, Vı́ctor, Kelly M. Cautivo, Shunxing Rong, et al.. (2013). Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2 lipodystrophic mice independent of hepatocyte leptin receptors. Journal of Lipid Research. 55(2). 276–288. 43 indexed citations
10.
Zhu, Xuewei, Shunxing Rong, Swapnil V. Shewale, et al.. (2012). Omega-3 Fatty Acids Ameliorate Atherosclerosis by Favorably Altering Monocyte Subsets and Limiting Monocyte Recruitment to Aortic Lesions. Arteriosclerosis Thrombosis and Vascular Biology. 32(9). 2122–2130. 57 indexed citations
11.
Rong, Shunxing, Qiang Cao, Jeongmin Seo, et al.. (2012). Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis. Journal of Lipid Research. 53(4). 686–695. 34 indexed citations
12.
Jia, Lin, Yinyan Ma, Shunxing Rong, et al.. (2010). Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis. Journal of Lipid Research. 51(11). 3135–3144. 56 indexed citations
13.
Chung, Soonkyu, Jenelle M. Timmins, MyNgan Duong, et al.. (2010). Targeted Deletion of Hepatocyte ABCA1 Leads to Very Low Density Lipoprotein Triglyceride Overproduction and Low Density Lipoprotein Hypercatabolism. Journal of Biological Chemistry. 285(16). 12197–12209. 53 indexed citations
14.
Cheng, Dongmei, et al.. (2009). Alternative splicing attenuates transgenic expression directed by the apolipoprotein E promoter-enhancer based expression vector pLIV11. Journal of Lipid Research. 51(4). 849–855. 6 indexed citations
15.
Rong, Shunxing, et al.. (2004). Screening Estrogenicity of Cadmium Using Uterotrophic Assay. Huanjing yu zhiye yixue. 21(5). 364–366. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriela Suchánková Breakdown of academic impact, for papers by Karen M. Kassel Breakdown of academic impact, for papers by Tetsuya Kitamine Breakdown of academic impact, for papers by Kavita Jadhav Breakdown of academic impact, for papers by Ariane Pessentheiner Breakdown of academic impact, for papers by Hélène Dehondt Breakdown of academic impact, for papers by Miguel Arévalo Rodríguez Breakdown of academic impact, for papers by Jeltje R. Goudriaan Breakdown of academic impact, for papers by Jingmei Song Breakdown of academic impact, for papers by Kaushala S. Jayawardana
Rankless by CCL
2026